To the Editor I agree with Kerr et al1 that an aspect of the Choosing Wisely (CW) campaign should be choosing a target wisely. Their concerns that unaggressive recommendations are being made that do not target wasteful testing may be valid. For this reason, the Canadian Rheumatology Association (CRA) CW recommendations were based on a specific methodology that adequately targeted problem areas.2 The CRA surveyed its society members to find tests or treatments that were deemed common and wasteful. Using this methodology, a Top 5 list was formed.2 Regional data confirm that the right choices were being made.
Ferrari R. Better Choices Concerning Rheumatoid Factor Testing. JAMA Intern Med. 2015;175(9):1586-1587. doi:10.1001/jamainternmed.2015.3012